9, 08209 Auerbach, Germany
The two compounds engage distinct but complementary receptor systems: Ipamorelin: Pentapeptide ghrelin/GHS receptor agonist selective for GH release without significant ACTH, cortisol, or prolactin elevation CJC-1295: GHRH analogue acting at the GHRH receptor on pituitary somatotrophs Combined research: Studies of pulsatile GH release frequently pair both compounds to examine synergistic effects across the two receptor pathways Bangkok Peptides supplies Ipamorelin individually as a 10mg vial and also stocks the pre-blended CJC-1295 / Ipamorelin combination for researchers using both compounds together
Your body adapts, and progress may slow temporarily
The CNS GLP- 1 receptors are not necessary for the physiological regulation of blood glucose levels by endogenous GLP- 1 or the pharmacological control of glucose homeostasis that depends on GLP- 1 receptors, although further research is needed to investigate the possible role of GLP- 1 receptors expressed outside the beta cell, including within the enteric and peripheral nervous systems, in improving beta cell function through enteral glucose mediation [70, 84]
These differences can impact the medications side effects, effectiveness, and cost factors that are essential to consider when choosing between the two
